Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
AVADEL PHARMACEUTICALS PLC (AVDL) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 144 Form 144 - Report of proposed sale of securities:
08/10/2023 SC 13G JANUS HENDERSON GROUP PLC reports a 12.3% stake in AVADEL PHARMACEUTICALS PLC
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 8-K Quarterly results
Docs: "AVADEL PHARMACEUTICALS PLC CONDENSED CONSOLIDATED STATEMENTS OF LOSS"
08/03/2023 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ...
08/03/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "AMENDMENT TO THE AVADEL PHARMACEUTICALS PLC 2020 OMNIBUS INCENTIVE COMPENSATION PLAN"
05/31/2023 8-K Other Events  Interactive Data
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/05/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Execution Version AVADEL FINANCE CAYMAN LIMITED, as Notes Issuer AND AVADEL PHARMACEUTICALS PLC, as Guarantor AND THE BANK OF NEW YORK MELLON, as Trustee INDENTURE Dated as of April 3, 2023 6.00% Exchangeable Senior Notes due 2027"
04/03/2023 8-K Other Events  Interactive Data
03/30/2023 8-K Quarterly results
03/30/2023 8-K/A Quarterly results
03/29/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
03/29/2023 10-K Annual Report for the period ended December 31, 2022
03/29/2023 8-K Quarterly results
03/22/2023 8-K Quarterly results
03/09/2023 SC 13G KOTLER KEVIN reports a 5.1% stake in Avadel Pharmaceuticals plc
03/02/2023 8-K Other Events  Interactive Data
02/24/2023 8-K Other Events  Interactive Data
02/14/2023 SC 13G/A GENDELL JEFFREY L reports a 8.4% stake in Avadel Pharmaceuticals plc
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/01/2023 8-K Quarterly results
11/18/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Avadel Pharmaceuticals Announces Favorable Ruling on Motion to Delist REMS Patent from FDA’ s Orange Book"
11/09/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/09/2022 8-K Quarterly results
11/04/2022 8-K Quarterly results
09/30/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
09/13/2022 EFFECT Form EFFECT - Notice of Effectiveness:
08/31/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
08/25/2022 8-K Other Events  Interactive Data
08/09/2022 10-Q Quarterly Report for the period ended June 30, 2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy